Vancouver, British Columbia–(Newsfile Corp. – June 3, 2020) – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD6) (WKN: A14XHT) (“COOL”) is pleased to announce that it will establish a Shareholder Advisory Board (the “Advisory Board”). The advisory board will consist of three current shareholders who have had interest and involvement in the Company for several years. The team will use their public market knowledge to help improve investor relations between the Company and its shareholders.

The three members selected to the Shareholder Advisory Board will be Dwane Friesen, Claude LaPointe and Vikrum Rajpal. The Advisory Board and the Company will meet weekly, these meetings will consist of the Company sharing the investor relations information and the Company will consider the Advisory Board’s opinions and shareholder perspectives. The Advisory Board will be held to the same level of confidentiality as the Company’s Corporate Board Members. The positions will be reviewed on a yearly basis by the Board of Directors of the Company. In addition to the position on the Advisory Board member, Mr. Rajpal will act as the Company’s social media representative updating Company information for the shareholders and investors interests.

Core One Labs’ CEO, Brad Eckenweiler, stated, “The Company is very appreciative of the commitment that our new Advisory Board members have already exhibited in taking the time to visit the facility in California (prior to travel restrictions) and to see and understand first-hand the progress and future plans of the Company. The involvement of this Advisory Board is important and this group has shown a keen interest in helping the Company succeed. Clearly there are new challenges with the outbreak of COVID-19 and social distancing and because of these factors clear and timely information is increasingly important. I believe going forward that this group of individuals will be an asset to the Company and its’s shareholders.” Advisory Board member, Vik Rajpal, stated, “I am looking forward to representing the Company’s vision on the Advisory Board and as additional IR. I’m also excited to assist the Company as we move to achieving operational profitability.”

  Subscribe to news from
Core One Labs

Be the first to know when breaking news are released.

Update: Given the continuing situation with the COVID-19 restrictions, the Company’s facility is being operated by only essential personnel. The nature of the operation, which includes the cultivation of medicinal cannabis, is considered an essential business in California and doesn’t require a complete shutdown. One benefit to our employees working at the facility is the advantage of our controlled environment using the same Ultraviolet Germicidal Irradiation Method used in Hospitals and Laboratories to fight viruses.

The Company will continue to update the market as information becomes available, and urges everyone to please take care of each other and be patient and compassionate with your co-workers, family, friends and neighbors during this extraordinary time of uncertainty.

About Core One Labs Inc.

Core One Labs Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company’s technology produces infused strips (like breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company’s technology, tests for quality and composition of all the ingredients used in every strip which results in a delivery system that is safe, consistent and effective. In addition, through its efforts to develop a better CannaStripsTM product, the Company has developed considerable expertise in cannabis extraction and nursery activities. The operational expertise developed by the Company as a result of these efforts has created new market opportunities for the Company in white label sales.

Core One Labs Inc.
Brad Eckenweiler
CEO & Director

[email protected]

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by several material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.

To view the source version of this press release, please visit